Review Article| Volume 32, ISSUE 2, P373-381, April 2023

Download started.


Lobectomy or Total Thyroidectomy—Where Is the Pendulum now for Differentiated Thyroid Cancer?

  • Oliver J. Fackelmayer
    Corresponding author. General, Endocrine & Metabolic Surgery, University of Kentucky, 125 East Maxwell Street, Suite 302, Lexington, KY 40508.
    Divsion of General, Endocrine and Metabolic Surgery, University of Kentucky, Lexington, KY 40508, USA

    General, Endocrine & Metabolic Surgery, University of Kentucky, 125 East Maxwell Street, Suite 302, Lexington, KY 40508, USA
    Search for articles by this author
  • William B. Inabnet III
    Divsion of General, Endocrine and Metabolic Surgery, University of Kentucky, Lexington, KY 40508, USA

    Department of Surgery, University of Kentucky College of Medicine, UK HealthCare, 800 Rose Street, MN268, Lexington, KY 40508, USA
    Search for articles by this author


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Surgical Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Haugen B.R.
        • Alexander E.K.
        • Bible K.C.
        • et al.
        2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
        Thyroid. 2016; 26: 1-133
        • Mayson S.E.
        • Chan C.M.
        • Haugen B.R.
        Tailoring the approach to radioactive iodine treatment in thyroid cancer.
        Endocr Relat Cancer. 2021; 28: T125-T140
        • Momesso D.P.
        • Vaisman F.
        • Yang S.P.
        • et al.
        Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine.
        J Clin Endocrinol Metab. 2016; 101: 2692-2700
        • Maher D.I.
        • Goare S.
        • Forrest E.
        • et al.
        Routine Preoperative Laryngoscopy for Thyroid Surgery Is Not Necessary Without Risk Factors.
        Thyroid. 2019; 29: 1646-1652
        • Patel K.N.
        • Yip L.
        • Lubitz C.C.
        • et al.
        The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.
        Ann Surg. 2020; 271: e21-e93
        • Xing M.
        • Liu R.
        • Liu X.
        • et al.
        BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
        J Clin Oncol. 2014; 32: 2718-2726
        • Jonklaas J.
        • Sarlis N.J.
        • Litofsky D.
        • et al.
        Outcomes of patients with differentiated thyroid carcinoma following initial therapy.
        Thyroid. 2006; 16: 1229-1242
        • Fackelmayer O.J.
        • Wu J.X.
        • Yeh M.W.
        Endocrine Surgery: Management of Postoperative Complications Following Endocrine Surgery of the Neck.
        Surg Clin North Am. 2021; 101: 767-784
        • Hauch A.
        • Al-Qurayshi Z.
        • Randolph G.
        • et al.
        Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons.
        Ann Surg Oncol. 2014; 21: 3844-3852
        • Schumm M.A.
        • Lechner M.G.
        • Shu M.L.
        • et al.
        Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer.
        Endocr Pract. 2021; 27: 691-697
        • Chen W.
        • Li J.
        • Peng S.
        • et al.
        Association of Total Thyroidectomy or Thyroid Lobectomy With the Quality of Life in Patients With Differentiated Thyroid Cancer With Low to Intermediate Risk of Recurrence.
        JAMA Surg. 2022; 157: 200-209
        • Knappe L.
        • Giovanella L.
        Life after thyroid cancer: the role of thyroglobulin and thyroglobulin antibodies for postoperative follow-up.
        Expert Rev Endocrinol Metab. 2021; 16: 273-279
        • Giovanella L.
        • Ceriani L.
        • Garo M.L.
        Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis.
        Clin Chem Lab Med. 2022; 60: 1091-1100
        • Matsuzu K.
        • Sugino K.
        • Masudo K.
        • et al.
        Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
        World J Surg. 2014; 38: 68-79
        • Barney B.M.
        • Hitchcock Y.J.
        • Sharma P.
        • et al.
        Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer.
        Head Neck. 2011; 33: 645-649
        • Mendelsohn A.H.
        • Elashoff D.A.
        • Abemayor E.
        • et al.
        Surgery for papillary thyroid carcinoma: is lobectomy enough?.
        Arch Otolaryngol Head Neck Surg. 2010; 136: 1055-1061
        • Haigh P.I.
        • Urbach D.R.
        • Rotstein L.E.
        Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer.
        Ann Surg Oncol. 2005; 12: 81-89
        • Nixon I.J.
        • Ganly I.
        • Patel S.G.
        • et al.
        Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy.
        Surgery. 2012; 151: 571-579
        • Pasqual E.
        • Sosa J.A.
        • Chen Y.
        • et al.
        Trends in the Management of Localized Papillary Thyroid Carcinoma in the United States (2000-2018).
        Thyroid. 2022; (published online ahead of print, 2022 Mar 15)
        • McDow A.D.
        • Saucke M.C.
        • Marka N.A.
        • et al.
        Thyroid Lobectomy for Low-Risk Papillary Thyroid Cancer: A National Survey of Low- and High-Volume Surgeons.
        Ann Surg Oncol. 2021; 28: 3568-3575
        • Puttergill B.
        • Khan S.
        • Christakis I.
        • et al.
        Thyroid lobectomy for low-risk thyroid cancers.
        Ann R Coll Surg Engl. 2022; 104: 113-116
        • Song E.
        • Han M.
        • Oh H.S.
        • et al.
        Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence.
        Thyroid. 2019; 29: 64-70
        • Bosset M.
        • Bonjour M.
        • Castellnou S.
        • et al.
        Long-Term Outcome of Lobectomy for Thyroid Cancer.
        Eur Thyroid J. 2021; 10: 486-494
        • Bojoga A.
        • Koot A.
        • Bonenkamp J.
        • et al.
        The Impact of the Extent of Surgery on the Long-Term Outcomes of Patients with Low-Risk Differentiated Non-Medullary Thyroid Cancer: A Systematic Meta-Analysis.
        J Clin Med. 2020; 9: 2316
        • Kuba S.
        • Yamanouchi K.
        • Hayashida N.
        • et al.
        Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study.
        Int J Surg. 2017; 38: 143-148
        • Matsuura D.
        • Yuan A.
        • Harris V.
        • et al.
        Surgical Management of Low-/Intermediate-Risk Node Negative Thyroid Cancer: A Single-Institution Study Using Propensity Matching Analysis to Compare Thyroid Lobectomy and Total Thyroidectomy.
        Thyroid. 2022; 32: 28-36
        • Wang L.Y.
        • Migliacci J.C.
        • Tuttle R.M.
        • et al.
        Management and outcome of clinically evident neck recurrence in patients with papillary thyroid cancer.
        Clin Endocrinol (Oxf). 2017; 87: 566-571
        • Park J.H.
        • Yoon J.H.
        Lobectomy in patients with differentiated thyroid cancer: indications and follow-up.
        Endocr Relat Cancer. 2019; 26: R381-R393
        • Shokoohi A.
        • Berthelet E.
        • Gill S.
        • et al.
        Treatment for Recurrent Differentiated Thyroid Cancer: A Canadian Population Based Experience.
        Cureus. 2020; 12: e7122